Author review tools

Overview

Guillaume Gaullier is an active structural and chromatin biology researcher whose publications span high-quality reviews and original cryo-EM and biochemical studies addressing nucleosome structure, chromatin remodellers such as ALC1, PARP interactions, and telomere proteins. His work is collaborative, often coauthored with groups specializing in cryo-EM and chromatin biochemistry, and includes papers in high-visibility journals.

Representative high-impact contributions

• Field review synthesizing nucleosome advances: Nucleosome review 2018
• Mechanistic cryo-EM and biochemistry on ALC1: ALC1 cryo-EM 2021
• Recent directed sliding mechanism paper: ALC1 directional sliding 2024

Citation and productivity metrics

Public bibliometrics indicate moderate overall citation impact and steady productivity: an h index reported in aggregate sources around 7 to 9, total citations in the low hundreds, and roughly 23–36 works depending on source aggregation. These values place Gaullier as a solid midcareer contributor in structural chromatin biology rather than a high citation outlier; however several individual works are field-shaping (see above).

Key references for metrics and top works: Nucleosome review 2018

Strengths

• Technical competency in cryo-EM and reconstituted chromatin assays demonstrated by structural papers and careful pairing with biochemical and single-molecule data (ALC1 cryo-EM 2021).
• Ability to produce synthesis pieces that are broadly used by the community (high-cited 2018 review) indicating good literature integration skills (Nucleosome review 2018).
• Collaborative network with established labs (Luger, Deindl, others) enhancing access to cryo-EM infrastructure and multidisciplinary expertise — reflected in coauthorships on methodologically demanding papers (ALC1 cryo-EM 2021).

Limitations and blindspots

• Moderate bibliometric footprint: h index and total citations are respectable but not exceptional for structural biology leaders; breadth of independent first/senior author high-impact papers is limited relative to top field leaders, which may reflect collaborative roles or midcareer stage (metrics cited above).
• Focus on molecular mechanism and in vitro reconstituted systems — powerful for mechanistic dissection but limits direct evidence of in vivo physiological importance in some studies; complementary cellular or organismal validation is less prominent in the available set of representative works (ALC1 cryo-EM 2021).
• Potential citation clustering: several high-cited works are reviews or collaborative cryo-EM papers; the independent intellectual leadership (as measured by single-author conceptual advances or multiple last-author papers in top-tier journals) is less clear from the available data.

Possible sources of bias in judging the work

Assessing an author through bibliometrics and a subset of papers risks overemphasizing citation-rich review articles and collaboration-driven cryo-EM papers; disciplinary practices (large author lists, shared cryo facilities) can inflate group-level impact while obscuring individual contributions. External influences such as collaborative funding, instrument access, and field citation norms should be considered.

Reproducibility and methodological quality

Selected structural papers pair cryo-EM with orthogonal biochemical validation and single-molecule assays (2021 and 2024 ALC1 papers), which strengthens internal validity and mechanistic inference; these multimodal approaches are best practice for robust mechanistic claims and help mitigate single-method artifacts (ALC1 directional sliding 2024).

Concluding evaluation

Gaullier is a competent, methodologically rigorous structural chromatin scientist whose strengths are in cryo-EM, chromatin reconstitution, and integrative mechanistic studies; his work includes both high-value community syntheses and experimental advances on ALC1 and PAR-related chromatin regulation. Metrics place him as a solid midcareer contributor with several field-influencing outputs, and his trajectory suggests continued impactful contributions provided he maintains independent leading roles and increases in vivo/physiological validation.

Next actions and tools

To explore the author further, run targeted bibliometric or paper-level analyses, or generate figures summarizing citation trajectories and coauthorship networks.